Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

318.78
Delayed Data
As of Jul 31
 +1.78 / +0.56%
Today’s Change
290.85
Today|||52-Week Range
480.18
-6.09%
Year-to-Date

Today’s Trading

Previous close317.00
Today’s open319.57
Day’s range312.70 - 322.35
Volume2,261,458
Average volume (3 months)1,904,566
Market cap$75.2B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+58.39%
Earnings growth (this year)+15.46%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+39.61%
P/E ratio21.6
Price/Sales8.30
Price/Book6.94

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...+0.07+0.17%
BXLTBaxalta Inc+0.92+2.88%
AMGNAmgen+4.90+2.85%
XONIntrexon Corp+1.83+2.89%
Data as of 4:04pm ET, 07/31/2015

Financials

Next reporting dateOctober 20, 2015
EPS forecast (this quarter)$3.92
Annual revenue (last year)$9.7B
Annual profit (last year)$2.9B
Net profit margin30.27%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
George A. Scangos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts